J. Aalders

发表

Endometrial cancer--revisiting the importance of pelvic and para aortic lymph nodes.

G. Thomas, J. Aalders, 2007, Gynecologic oncology.

Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva.

P. V. van Diest, A. V. D. Van Der Zee, R. Verheijen, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Postoperative External Irradiation and Prognostic Parameters in Stage I Endometrial Carcinoma: CLINICAL AND HISTOPATHOLOGIC STUDY OF 540 PATIENTS

V. Abeler, P. Kolstad, M. Onsrud, 1980, Obstetrics and gynecology.

A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma.

E. Vellenga, N. Mulder, E. de Vries, 1991, Cancer research.

Squamous cell carcinoma of the vulva: a review of 424 patients, 1956-1974.

P. Kolstad, T. Iversen, J. Aalders, 1980, Gynecologic oncology.

Future Developments in Radiation Therapy for Endometrial Carcinoma

C. Creutzberg, J. Aalders, 2005 .

Lymphvascular space involvement: an independent prognostic factor in endometrial cancer.

H. Boezen, H. Hollema, A. V. D. Van Der Zee, 2005, Gynecologic oncology.

Aspects of surgery in ovarian and endometrial carcinoma.

J. Neijt, J. Aalders, 1993, European journal of cancer.

Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment.

H. D. de Bruijn, E. D. de Vries, W. Sluiter, 2002, International journal of radiation oncology, biology, physics.

Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancer.

E. D. de Vries, H. Rosing, J. Beijnen, 2002, Gynecologic oncology.

Phase II study of high-dose megestrol acetate in patients with advanced ovarian carcinoma.

J. Vermorken, S. Pecorelli, N. Rotmensz, 1994, European journal of cancer.

Patients with squamous cell versus adeno(squamous) carcinoma of the cervix, what factors determine the prognosis?

J. Bouma, J. Aalders, D. J. Tinga, 1991, International Journal of Gynecologic Cancer.

CA 125: a useful marker in endometrial carcinoma.

G. Fleuren, H. D. de Bruijn, H. Bruijn, 1986 .

Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors

G. Fleuren, J. Trimbos, H. D. de Bruijn, 1987, Cancer.

Effective high-dose chemotherapy with autologous bone marrow infusion in resistant ovarian cancer.

N. Mulder, J. Bouma, D. Sleijfer, 1984, Gynecologic oncology.

Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB.

J. Bouma, J. Aalders, P. R. Timmer, 1990, Gynecologic oncology.

Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.

H. Hollema, H. D. de Bruijn, A. V. D. Van Der Zee, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I and pharmacokinetic study of intraperitoneal topotecan

H. Rosing, J. Beijnen, P. Willemse, 2001, British Journal of Cancer.

Risks and benefits of cisplatin in ovarian cancer. A quality-adjusted survival analysis.

N. Mulder, E. de Vries, J. Bouma, 1990, European Journal of Cancer.

Intraperitoneal human recombinant interferon alpha-2b in minimal residual ovarian cancer.

N. Mulder, E. de Vries, J. Bouma, 1990, European journal of cancer.

Tumor Markers CA 125, Squamous Cell Carcinoma Antigen, and Carcinoembryonic Antigen in Patients With Adenocarcinoma of the Uterine Cervix

G. Fleuren, H. D. de Bruijn, J. Aalders, 1989, Obstetrics and gynecology.

Less Gastrointestinal Toxicity After Adjuvant Radiotherapy on a Small Pelvic Field Compared to a Standard Pelvic Field in Patients With Endometrial Carcinoma

H. Boezen, H. Hollema, A. V. D. Van Der Zee, 2012, International Journal of Gynecologic Cancer.

CA 125: A useful marker in endometrial carcinoma

H. D. de Bruijn, G. Fleuren, J. Aalders, 1987, American journal of obstetrics and gynecology.

Recombinant human interleukin-3 to dose-intensify carboplatin and cyclophosphamide chemotherapy in epithelial ovarian cancer: a phase I trial.

N. Mulder, E. de Vries, B. Mull, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients.

V. Abeler, P. Kolstad, J. Aalders, 1984, Gynecologic oncology.

Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: a clinical and histopathological study of 175 patients.

V. Abeler, P. Kolstad, J. Aalders, 1984, Gynecologic oncology.

Individualized Treatment of Stage I Carcinoma of the Vulva

V. Abeler, T. Iversen, J. Aalders, 1981, Obstetrics and gynecology.

Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.

H. Boezen, H. Hollema, A. V. D. Van Der Zee, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cancer-associated antigen CA 195 in patients with mucinous ovarian tumours: a comparative analysis with CEA, TATI and CA 125 in serum specimens and cyst fluids.

H. D. de Bruijn, K. T. ten Hoor, H. Boonstra, 1993, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

CA-125 in ovarian cancer: relation between half-life, doubling time and survival.

N. Mulder, E. de Vries, D. Sleijfer, 1991, European journal of cancer.

The effect of abdominal surgery on the serum concentration of the tumour‐associated antigen CA 125

A. Zee, H. Bruijn, A. H. Boontje, 1990, British journal of obstetrics and gynaecology.

Endometrial carcinoma with cervical involvement (Stage II): Prognostic factors and value of combined radiological-surgical treatment

V. Abeler, P. Taylor, M. Onsrud, 1982 .

Long-term survival after vinblastine, bleomycin, and cisplatin treatment in patients with germ cell tumors of the ovary: An update

J. Bouma, E. Vries, D. Sleijfer, 1987 .

Gynecologic examination and cervical biopsies after (chemo) radiation for cervical cancer to identify patients eligible for salvage surgery.

H. Hollema, A. V. D. Van Der Zee, P. Willemse, 2006, International journal of radiation oncology, biology, physics.

Noninvasive detection of inguinofemoral lymph node metastases in squamous cell cancer of the vulva by L-

H. Hollema, A. V. D. Van Der Zee, J. Pruim, 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

The value of cancer antigen 125 (CA 125) during treatment and follow-up of patients with ovarian cancer.

H. D. de Bruijn, A. V. D. Van Der Zee, J. Aalders, 1997, Current opinion in obstetrics & gynecology.

Hemolytic uremic syndrome in a patient on cis-platinum, vinblastine and bleomycin

E. Vries, J. V. D. Meer, P. Willemse, 2004, Journal of Cancer Research and Clinical Oncology.

Concurrent chemo- and radiotherapy in patients with locally advanced carcinoma of the cervix.

H. Hollema, H. D. de Bruijn, E. D. de Vries, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Radical Surgery Compared with Intracavitary Cesium Followed by Radical Surgery in Cervical Carcinoma Stage Ib

H. Hollema, J. Bouma, J. Aalders, 1990, Acta obstetricia et gynecologica Scandinavica.

Palmar fasciitis and arthritis in a patient with an extraovarian adenocarcinoma of the coelomic epithelium.

N. Mulder, D. Sleijfer, P. Willemse, 1991, Annals of the rheumatic diseases.

Prognostic factors and changing trends in the treatment of Stage I endometrial cancer: a clinical and histopathological study of 182 patients.

S. Poppema, B. G. Szabó, J. Aalders, 1984, International journal of radiation oncology, biology, physics.

Symptomatology, localization and treatment of recurrent cervical carcinoma

J. Bouma, H. Boonstra, J. Aalders, 1991, International Journal of Gynecologic Cancer.

Cancer of the uterine cervix: sensitivity and specificity of serum squamous cell carcinoma antigen determinations.

H. Hollema, H. D. de Bruijn, K. Groenier, 1990, Gynecologic oncology.

Malignant struma ovarii treated by ovariectomy, thyroidectomy, and 131I administration

J. Oosterhuis, D. Sleijfer, D. Piers, 1987, Cancer.

The Clinical Value of Squamous Cell Carcinoma Antigen in Cancer of the Uterine Cervix

H. Hollema, H. D. de Bruijn, A. V. D. Van Der Zee, 1998, Tumor Biology.

Circulating antibodies against human chorionic gonadotropin following trophoblastic disease.

H. D. de Bruijn, J. Aalders, A. Groenhuis, 1984, Gynecologic oncology.

Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).

N. Mulder, J. Bouma, D. Sleijfer, 1984, Cancer treatment reports.

Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva.

H. D. de Bruijn, J. Bouma, J. Aalders, 1989, Gynecologic oncology.

Risk factors in gestational trophoblastic disease, and consequences for primary treatment.

H. D. de Bruijn, P. Willemse, H. Dijkema, 1986, European journal of obstetrics, gynecology, and reproductive biology.

Karyotyping and DNA flow cytometry of metastatic ovarian yolk sac tumor.

J. Oosterhuis, B. de Jong, J. Aalders, 1990, Cancer genetics and cytogenetics.

Vulvar carcinoma

H. Hollema, M. Mourits, A. van der Zee, 2002, Cancer.

Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum ca 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics

G. Fleuren, H. D. de Bruijn, K. Groenier, 1990, Cancer.

Radical surgery after preoperative intracavitary radiotherapy for Stage IB and IIA carcinoma of the uterine cervix.

J. Bouma, J. Aalders, P. R. Timmer, 1984, Gynecologic oncology.

Anticoagulants and the formation of lymphocysts after pelvic lymphadenectomy in gynecologic and oncologic operations.

J. Bouma, H. Kragt, J. Aalders, 1986, Surgery, gynecology & obstetrics.

Stage IV endometrial carcinoma: a clinical and histopathological study of 83 patients.

V. Abeler, P. Kolstad, J. Aalders, 1984, Gynecologic oncology.

Receptors and the Prevention of Endometrial Cancer

J. Aalders, 1986 .

Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva.

H. Hollema, A. V. D. Van Der Zee, D. Piers, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Total pelvic exenteration: A justified procedure

J. Oldhoff, J. Aalders, J. Plukker, 1993, The British journal of surgery.

Cell biological markers of drug resistance in ovarian carcinoma.

H. Hollema, H. D. de Bruijn, A. V. D. Van Der Zee, 1995, Gynecologic oncology.

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic Factors and Treatment of Endometrial carcinoma. A clinical and histopathological study

J. Aalders, 1982 .

Sentinel lymph node detection in locally recurrent carcinoma of the vulva

H. Hollema, D. Piers, J. Aalders, 2001, BJOG : an international journal of obstetrics and gynaecology.

Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary results

J. Neijt, E. Vries, W. W. Bokkel Huinink, 2004, Cancer Chemotherapy and Pharmacology.

Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma

E. D. de Vries, R. Otter, M. Schaapveld, 2006, Cancer.

High-dose chemotherapy with autologous bone marrow transplantation in patients with refractory ovarian cancer.

N. Mulder, E. de Vries, D. Sleijfer, 1989, European journal of cancer & clinical oncology.

Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.

H. Hollema, H. D. de Bruijn, A. V. D. Van Der Zee, 2000, Gynecologic oncology.

Minimum Extension and Appropriate Topographic Position of Tissue Destruction for Treatment of Cervical Intraepithelial Neoplasia

J. Oosterhuis, H. Boonstra, J. Aalders, 1990, Obstetrics and gynecology.

Treatment of Clinical Early Endometrial Carcinoma; Indications for Lymphonodectomy

J. Aalders, 1991 .

Carboplatin with cyclophosphamide in patients with advanced ovarian cancer: an efficacy and quality-adjusted survival analysis

E. D. de Vries, M. Kloppenburg, P. Willemse, 1992, International Journal of Gynecologic Cancer.

Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.

H. Hollema, H. D. de Bruijn, A. V. D. Van Der Zee, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of Cryolesions in the Uterine Cervix: Application Techniques, Extension, and Failures

J. Koudstaal, H. Boonstra, J. Aalders, 1990, Obstetrics and gynecology.

Role of an early second-look laparotomy in ovarian cancer.

J. Bouma, D. Sleijfer, P. Willemse, 1989, Gynecologic oncology.

Endometrial carcinoma with cervical involvement (stage II): prognostic factors and value of combined radiological-surgical treatment.

V. Abeler, P. Taylor, M. Onsrud, 1982, Gynecologic oncology.

Levels of CA 125 in patients with recurrent carcinoma of the fallopian tube: two case histories.

H. D. de Bruijn, P. Willemse, J. Aalders, 1987, European journal of obstetrics, gynecology, and reproductive biology.

Transformation of histological tumor type of the cervix expressed in different tumor markers in the serum.

H. D. de Bruijn, J. Oosterhuis, J. Aalders, 1990, Gynecologic oncology.

Endodermal sinus tumor of the ovary during pregnancy: a case report.

H. D. de Bruijn, A. V. D. Van Der Zee, E. D. de Vries, 1991, American journal of obstetrics and gynecology.

Vulvar carcinoma. The price of less radical surgery.

H. Hollema, A. Zee, M. Mourits, 2002 .